Williams B T, Roberts E F, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 10393346 B2, 2017-02-01.
Stevens L M, Fischer A B, Patel M V. "Method for the Synthesis of 2-Methyl-1-(piperidin-4-ylmethyl)-1H-imidazo[4,5-c]pyridine" [P]. US Patent, US 10415257 B2, 2020-07-01.
发明人林芳,马晓峰,唐晓军. "A Process for Preparing High-Purity 2-Methyl-1-(piperidin-4-ylmethyl)-1H-imidazo[4,5-c]pyridine" [P]. 中国发明专利, 专利号 CN 116683173 A, 授权公告日 2018-01-10.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2019, 1538, (6), 1722-1730.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2019, 1808, 1906-1927.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-1-(piperidin-4-ylmethyl)-1H-imidazo[4,5-c]pyridine Using HRMS and NMR". Biomed. Chromatogr., 2013, 557, (7), 7565-7589.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1948, 497-502.